Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

NCT02642809 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Cancer of the Esophagus

Interventions

DRUG: Pembrolizumab
RADIATION: Brachytherapy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]